September 20, 2017
Add to Twitter
English | عربي
 
Safety and efficacy results from the INJOURNEY™ trial investigating OFEV® (nintedanib) with add-on pirfenidone provide new data to support nintedanib’s key role in IPF
 
News Agencies Feed